A National Survey on the Prevalence and Impact of Multiple Pharmacy Use in Specialty Pharmacy

Health Services Accessibility Clinical Trial

Official title:

A National Survey on the Prevalence and Impact of Multiple Pharmacy Use in Specialty Pharmacy

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05035225
• Other study ID #: IRB00277792
• Status: Enrolling by invitation
• Phase: N/A
• Start date: July 31, 2023
• Est. completion date: November 30, 2024

Study information

• Verified date: May 2024
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Specialty medications often have dispensing restrictions which can be dictated by manufacturer limited distribution strategies, narrow insurance networks, or a combination of both. Unfortunately, this may result in patients being required to use 2 or more pharmacies to fill their prescription medications; this is referred to as multiple pharmacy use (MPU). The investigators' plan is to administer a survey to patients who have been prescribed one or more specialty medications to evaluate the prevalence of MPU in this population as well as to investigate patients' attitudes about MPU and potential factors increasing the likelihood of MPU

Description:

The investigators will identify patients from participating member sites via a review of prescribing records for specific specialty medications. Patients will be contacted via telephone to explain the purpose and risk of the study. Consented patients will then be asked a series of 11 questions about their attitudes and experience with taking and obtaining their specialty medication(s). Additional demographic and clinical information about patients will be collected via chart review.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 800
• Est. completion date: November 30, 2024
• Est. primary completion date: September 30, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects 18 years of age or older

• English-speakers

• An active patient of a performance institution and ability to provide informed consent to participate with the survey

• Electronically prescribed at least one specialty medication by a performance site provider, which can be either a new or renewed order, within the last 3 months

Exclusion Criteria:

• Subjects less than 18 years of age

• Non-English speakers

• Patients that cannot or are unwilling to provide consent

• Patients who have not had a new or renewed specialty medication prescription order placed electronically within the last 3 months

Related Conditions & MeSH terms

• Health Services Accessibility

Intervention

Other:
• Survey
Multiple Pharmacy Use Survey

Locations

Country	Name	City	State
United States	Johns Hopkins Hospital	Baltimore	Maryland

Sponsors (5)

Lead Sponsor	Collaborator
Johns Hopkins University	The Cleveland Clinic, University of California, Los Angeles, University of Illinois at Chicago, University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of Patients using Multiple Pharmacies	Of all patients consented, the percentage of patients using more than one pharmacy to obtain their medications	Within one year of study initiation
Secondary	Self-reported adherence and barriers	Patient response to questions about having missed doses in the past month	Within one year of study initiation
Secondary	Method of obtaining medications	Patient response to questions about distance from pharmacy and how prescriptions are primarily obtained	Within one year of study initiation
Secondary	Experience with obtaining and administering medications	Patient response to questions about how easy it is for patients to obtain and administer medication	Within one year of study initiation